{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Elsamitrucin",
  "nciThesaurus": {
    "casRegistry": "97068-30-9",
    "chebiId": "",
    "chemicalFormula": "C33H35NO13",
    "definition": "An heterocyclic antineoplastic antibiotic isolated from the bacterium Actinomycete strain J907-21.  Elsamitrucin intercalates into DNA at guanine-cytosine (G-C)-rich sequences and inhibits topoisomerase I and II, resulting in single-strand breaks and inhibition of DNA replication.",
    "fdaUniiCode": "ZTV0FOB6NU",
    "identifier": "C1080",
    "preferredName": "Elsamitrucin",
    "semanticType": "Antibiotic",
    "subclassOf": [
      "C1968",
      "C259"
    ],
    "synonyms": [
      "10-O-Elsaminosylelsarosylchartarin",
      "BBM 2478A",
      "BMY-28090",
      "BRN 5214813",
      "Benzo(h)(1)benzopyrano(5,4,3-cde)(1)ebnzopyran-5,12-dione,10((2-O-(2-amino-2,6-dideoxy-3-O-methyl-alpha-D-galactopyranosyl)-6-deoxy-3-C-methyl-beta-D-galactopyranosyl)oxy)-6-hydroxy-1-methyl",
      "ELSAMITRUCIN",
      "Elsamicin A",
      "Elsamitrucin",
      "Elsamitrucina",
      "Elsamitrucine",
      "Elsamitrucinum"
    ]
  }
}